Author

Lea Cohen-Attali

InsermORCID 0000-0002-6097-1840Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:development & morphogenesis· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Alexandra PolyanskyiD· 1 shared Alix Zhou· 1 shared Amir MoriD· 1 shared Aric Orbach· 1 shared Clotilde ThéryiD· 1 shared Coralie L. GuériniD· 1 shared Daniela Kaludjerski· 1 shared Eric RubinsteiniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexandra PolyanskyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Nano-flow cytometry of single extracellular vesicles reveals subpopulation differences across cell types and pharmacological perturbations

Nathalie Névo, Alix Zhou, Nicolas Ansart, Lea Cohen-Attali, Eric Rubinstein, Coralie L. Guérin, Lorena Martin Jaular, Clotilde Théry

This study uses nano-flow cytometry to analyze single extracellular vesicles, revealing subpopulation differences across cell types and drug treatments.

Journal of Extracellular Vesicles · Apr 1, 2026Peer-reviewedCell Biology

FTO regulates centrosome function and mitotic fidelity in cancers with chromosome instability (CIN)

Lea Cohen-Attali, Yelena Mostinski, Guy Biber, Daniela Kaludjerski, Mor Hanan, Reut Eshel, Alexandra Polyansky, Igor Pery, Aric Orbach, Rotem Karni, Amir Mor

This study shows FTO regulates centrosome function and mitotic fidelity, with CIN cancers being more sensitive to FTO inhibition.

bioRxiv · Mar 25, 2026 · PreprintCancer Biology